Aft, Forsyth & Company, Inc. Vertex Pharmaceuticals Inc Transaction History

Aft, Forsyth & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$207.02 - $241.31 $340,961 - $397,437	-1,647 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $923,264 - $1.23 Million	-4,460 Reduced 73.03%	1,647 $389,000
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $1.29 Million - $1.53 Million	5,043 Added 473.97%	6,107 $895,000
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $239,910 - $314,731	1,064 New	1,064 $309,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.